MXPA01001639A - Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. - Google Patents
Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.Info
- Publication number
- MXPA01001639A MXPA01001639A MXPA01001639A MXPA01001639A MXPA01001639A MX PA01001639 A MXPA01001639 A MX PA01001639A MX PA01001639 A MXPA01001639 A MX PA01001639A MX PA01001639 A MXPA01001639 A MX PA01001639A MX PA01001639 A MXPA01001639 A MX PA01001639A
- Authority
- MX
- Mexico
- Prior art keywords
- cpn
- chlamydia
- strain
- host
- pneumoniae
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56927—Chlamydia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Abstract
Como resumen de esta exposicion, la presente invencion proporciona un metodo de inmunizacion de un hospedero con acido nucleico, incluyendo al ADN, donde el hospedero incluye humanos, y la inmunizacion se hace contra enfermedades producidas por la infeccion con una cepa de Chlamydia, especificamente C. pneunomiae, empleando un vector que contiene una secuencia de nucleotidos que codifica para cualquiera de los siguientes polipeptidos: CPN100111, CPN100224, CPN100230, CPN100231, CPN100232, CPN100235, CPN100394 y CPN100395 de una cepa de Chlamydia pneumoniae y un promotor para efectuar la expresion de cualquiera de los polipeptidos en el hospedero. Son posibles modificaciones dentro del alcance de esta invencion.
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9718798P | 1998-08-20 | 1998-08-20 | |
| US9719598P | 1998-08-20 | 1998-08-20 | |
| US9719798P | 1998-08-20 | 1998-08-20 | |
| US9719698P | 1998-08-20 | 1998-08-20 | |
| US9718898P | 1998-08-20 | 1998-08-20 | |
| US9719098P | 1998-08-20 | 1998-08-20 | |
| US9718998P | 1998-08-20 | 1998-08-20 | |
| US9719198P | 1998-08-27 | 1998-08-27 | |
| US37677099A | 1999-08-17 | 1999-08-17 | |
| PCT/IB1999/001449 WO2000011183A2 (en) | 1998-08-20 | 1999-08-18 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01001639A true MXPA01001639A (es) | 2004-09-06 |
Family
ID=27578413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01001639A MXPA01001639A (es) | 1998-08-20 | 1999-08-18 | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1104470A2 (es) |
| JP (1) | JP2002523049A (es) |
| AU (1) | AU5297399A (es) |
| CA (1) | CA2341637A1 (es) |
| MX (1) | MXPA01001639A (es) |
| WO (1) | WO2000011183A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002531129A (ja) * | 1998-12-08 | 2002-09-24 | コリクサ コーポレイション | クラミジア感染の処置および診断のための化合物および方法 |
| GB0203403D0 (en) * | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
| US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
| GB0709373D0 (en) * | 2007-05-16 | 2007-06-27 | Thrombosis Res Inst | BCG-based anti-atheroma vaccine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996009320A1 (en) * | 1994-09-20 | 1996-03-28 | Hitachi Chemical Company, Ltd. | Antigenic polypeptide of chlamydia pneumoniae |
| WO1998006408A1 (en) * | 1996-08-14 | 1998-02-19 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| AU762606B2 (en) * | 1997-11-21 | 2003-06-26 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
-
1999
- 1999-08-18 MX MXPA01001639A patent/MXPA01001639A/es unknown
- 1999-08-18 CA CA002341637A patent/CA2341637A1/en not_active Abandoned
- 1999-08-18 EP EP99938465A patent/EP1104470A2/en not_active Withdrawn
- 1999-08-18 JP JP2000566437A patent/JP2002523049A/ja not_active Withdrawn
- 1999-08-18 AU AU52973/99A patent/AU5297399A/en not_active Abandoned
- 1999-08-18 WO PCT/IB1999/001449 patent/WO2000011183A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000011183A3 (en) | 2000-06-08 |
| AU5297399A (en) | 2000-03-14 |
| WO2000011183A2 (en) | 2000-03-02 |
| CA2341637A1 (en) | 2000-03-02 |
| EP1104470A2 (en) | 2001-06-06 |
| JP2002523049A (ja) | 2002-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| IL123667A0 (en) | Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and products | |
| AU3431497A (en) | DNA immunization against Chlaymdia infection | |
| IL161769A0 (en) | Anbtimicrobial polypeptides from pseudoplectania nigrella | |
| WO2000003685A3 (en) | Nitrilase homologs | |
| DE69840333D1 (de) | 2-m übergang des zellzyklus | |
| WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| DK0981631T3 (da) | Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme | |
| WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| FI961202A0 (fi) | Grb3-3-geeni, sen variantteja ja niiden käyttöjä | |
| WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| EP2172214A3 (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| WO1999051745A3 (en) | Dna immunization against chlamydia infection | |
| MXPA01001639A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2003012099A1 (en) | Chondroitin synthase | |
| WO2000026239A3 (en) | $i(chlamydia) antigens and corresponding dna fragments and uses thereof | |
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000026237A3 (en) | Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof | |
| WO2000006743A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000006739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001036455A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof |